Tell-tale signs of heightened stroke risk may appear up to 10 years earlier

Much steeper declines in cognitive skills and routine daily functioning already evident then

The tell-tale signs of a person’s susceptibility to a stroke may appear up to 10 years before the event, suggests research published online in the Journal of Neurology Neurosurgery & Psychiatry.

Stroke patients experienced much steeper declines in cognitive abilities and routine daily functioning, starting around a decade before their first stroke than people who didn’t have a stroke, the findings show.

Women, carriers of the APOE gene that is associated with Alzheimer’s disease, and those with fewer academic qualifications, seem to be at the greatest risk.

The deterioration in cognitive skills and the inability to carry out routine activities of independent daily living, which are common after a stroke, are attributable to a build-up of physiological changes. But it’s not clear when these changes actually start. 

To explore this further, the researchers repeatedly used various accredited tests to assess the cognitive abilities, such as memory, verbal fluency, reaction times, and manual dexterity,  of 14,712 Rotterdam Study* participants between 1990 and 2016.

The tests included the Mini Mental State Exam, widely used to assess memory problems and dementia severity; the Stroop task, which tests the speed of mental processing; the Purdue Pegboard test, which assesses manual dexterity.

They also assessed participants’ capacity for basic activities of independent daily living, such as washing, eating, and dressing (BADL), and more advanced activities, such as managing finances (IADL).

Participants’ medical records were then checked to monitor their health until 2018. Each person who had a stroke during the monitoring period was matched with three participants who hadn’t, based on age and sex.

The researchers then plotted the changes in cognition and daily functioning in both sets of participants, to include the 10 years before and the 10 years after a stroke. 

During an average monitoring period of 12.5 years,1662 participants had their first ever stroke. The average age at which this happened was 80.

Analysis of the test score patterns revealed clear differences in cognition and daily functioning between those who had a stroke and those who didn’t, up to 10 years before the event. 

Clinically significant differences were seen in Mini Mental State Exam results (around 6.5 years earlier), but which started to differ around 8 years beforehand; Stroop task (nearly 6 years earlier), but which started to differ around 10 years beforehand; and the Purdue Pegboard test (nearly 4 years earlier),but which started to differ around 9 years beforehand.

And scores for all cognitive tests continued to fall more rapidly years after the event in those who had had a stroke than they did in those who hadn’t. 

Differences in the basic and advanced daily functioning scores emerged 2 and 3 years earlier, respectively, and they too continued to fall more rapidly in those who had had a stroke in subsequent years.

Over half (1000; 60%) of those who had a stroke were women; and APOE gene carriers, and those with fewer academic qualifications--both proxy measures of what’s known as ‘cognitive reserve’--were more likely to be affected by the steeper declines in cognitive skills and daily functioning.

This is an observational study, and as such, can’t establish cause. And the researchers acknowledge certain limitations, which include the inability to stratify the trajectories by type of stroke and the absence of data on stroke severity. 

Nevertheless, they suggest their findings indicate that there might be tell-tale signs for those at high risk of a stroke many years in advance.

“Our findings demonstrated that future stroke patients start to deviate from stroke-free controls up to 10 years before the acute event, suggesting that individuals with cognitive and functional decline are at a higher risk of stroke and are possible candidates for prevention trials,” they write.

“The accelerated decline in cognition and daily functioning before stroke suggests that individuals with future stroke suffer from accumulating intracerebral damage years before the acute event, such as cerebral small vessel disease, neurodegeneration, and inflammation,” they explain.

Tags : #Stroke #AlzheimersDisease #APOEGene #JournalofNeurologyNeurosurgeryandPsychiatry

About the Author

Team Medicircle

Related Stories

Loading Please wait...


Trending Now

Prescribing Equality: Tackling Gender Disparities in India's Healthcare LeadershipDecember 07, 2023
Digitalizing Health: Generative AI's Impact Amplified by AWS Cloud in IndiaDecember 07, 2023
Eyes on the Future: Dr. Agarwal's Group Channels Rs 100 Crore for Cutting-edge Eye Hospitals Across KeralaDecember 06, 2023
Organ Transplant Scandal: Apollo Hospital Faces Government InquiryDecember 06, 2023
Breaking Barriers in Cancer Treatment: Max Healthcare's CAR-T Therapy PartnershipDecember 06, 2023
Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023